We thank Beuy Joob and Viroj Wiwanitkit for their comment about our article [1]. When we sent the paper to the Revue Neurologique (Paris), only one paper had been published. In this case report, the link between Guillain-Barré syndrome and COVID-19 was uncertain [2]. In our patient, no rash was present and the patient had not travelled in endemic areas for Dengue, reason why this diagnosis had not been discussed.
Disclosure of interest
The authors declare that they have no competing interest.
Footnotes
Camdessanche JP, Morel J,Pozzetto B, Paul S. COVID-19 may induce Guillain-Barré syndrome. Revue Neurologique; doi: 10.1016/j.neurol.2020.04.003. PII: S0035-3787(20)30522-1. (NEUROL 2240). Joob B, Wiwanitkit V. COVID-19 and Guillain-Barré syndrome. Revue Neurologique; doi:10.1016/j.neurol.2020.05.002. PII: S0035-3787(20)30559-2. (NEUROL 2258).
References
- 1.Camdessanché J.P., Morel J., Pozzetto B., Paul S., Tholance Y., Botelho-Nevers E. COVID-19 may induce Guillain-Barré syndrome. Rev Neurol. 2020 doi: 10.1016/j.neurol.2020.04.003. [pii: S0035-3787(20)30522-1, Epub ahead of print] [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Zhao H., Shen D., Zhou H., Liu J., Chen S. Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol. 2020;19(5):383–384. doi: 10.1016/S1474-4422(20)30109-5. [Epub 2020 Apr 1] [DOI] [PMC free article] [PubMed] [Google Scholar]